Sensirion_edited.jpg

PiKe Pharma GmbH

Health & Nutrition

PiKe Pharma GmbH develops small-molecule drugs for infectious diseases employing fragment-based synthesis of unique chemical libraries in combination with an innovative screening technology for the identification of novel protein-protein interaction inhibitors. The company was liquidated in 2015.

2000_W1_Carbofix.png
2008